OYLER JOHN 4
4 · BeOne Medicines Ltd. · Filed Mar 10, 2026
Research Summary
AI-generated summary of this filing
BeOne (ONC) CEO John Oyler Receives Stock Award
What Happened
John Oyler, CEO of BeOne Medicines (ONC), received two grants of performance share units on 2026-03-06 totaling 444,912 ordinary shares: 326,976 shares (vest in 2027) and 117,936 shares (vest in 2028). Both grants are reported as acquired at $0 (no cash paid). The awards are unvested and include accelerated vesting provisions upon a change of control or certain termination events.
Key Details
- Transaction date: 2026-03-06; Form 4 filed 2026-03-10 (filed within the typical two-business-day window).
- Grants: 326,976 shares (footnote F1, vests 2027) and 117,936 shares (footnote F2, vests 2028). Total = 444,912 shares. Price: $0.
- Shares owned after transaction: not specified in the provided excerpt.
- Notable footnotes: F1/F2 describe vesting schedules and accelerated vesting on change of control/termination. Other footnotes (F3–F7) in the filing note certain securities held in trusts/IRAs for which Oyler disclaims beneficial ownership.
Context
These are performance-based equity awards (not open-market purchases or sales). They represent future compensation contingent on service and/or performance and do not reflect an immediate cash investment by the insider. For retail investors, awards signal executive compensation/retention practices rather than direct insider buying or selling of existing stock.
Insider Transaction Report
- Award
Ordinary Shares
[F1]2026-03-06+326,976→ 5,491,339 total - Award
Ordinary Shares
[F2]2026-03-06+117,936→ 5,609,275 total
- 481,533(indirect: See Footnote)
Ordinary Shares
[F3] - 7,699,158(indirect: See Footnote)
Ordinary Shares
[F4] - 28,204,115(indirect: See Footnote)
Ordinary Shares
[F5] - 9,545,000(indirect: See Footnote)
Ordinary Shares
[F6] - 102,188(indirect: See Footnote)
Ordinary Shares
[F7]
Footnotes (7)
- [F1]Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2027, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested shares are subject to accelerated vesting upon change of control or certain termination events.
- [F2]Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2028, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested shares are subject to accelerated vesting upon change of control or certain termination events.
- [F3]These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.
- [F4]These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- [F5]These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- [F6]These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
- [F7]These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.